Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation

Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation

Background : Pretransplant therapies such as rituximab and plasmapheresis have led to an increase in ABO-incompatible (ABOi) living donor liver transplantation (LDLT), thus helping to overcome organ shortages. This study evaluated the changes in anti-A/B titers and CD19 levels over time in patients...

Full description

Bibliographic Details
Main Authors: Suk Kyun Hong, Kwang-Woong Lee, Jae-Yoon Kim, Jaewon Lee, Jiyoung Kim, Hyun Hwa Choi, Su young Hong, Jeong-Moo Lee, YoungRok Choi, Nam-Joon Yi, Kyung-Suk Suh
Format: Article
Language:English
Published: Korean Society for Transplantation 2023-09-01
Series:Korean Journal of Transplantation
Subjects:
liver transplantation; abo blood-group system; rituximab; polymorphism
Online Access:http://www.ekjt.org/journal/view.html?doi=10.4285/kjt.23.0031

Internet

http://www.ekjt.org/journal/view.html?doi=10.4285/kjt.23.0031

Similar Items